Physician profile
Amber K Seiler
NPI 1649637778
$54,921.93
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $28K · 2023: $9,799 · 2024: $2,380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,677 · Travel and Lodging: $2,351 · Food and Beverage: $1,456 · Consulting Fee: $650 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,677.00 |
| Travel and Lodging | $2,351.27 |
| Food and Beverage | $1,455.90 |
| Consulting Fee | $650.00 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36,728.47 | 2021-2024 | Linq II, Paceart System Ecg Module, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $13,764.42 | 2021-2022 | |
| Abbott Laboratories | $1,208.53 | 2021-2024 | Accent, Confirm Rx, Aveir |
| Pfizer INC. | $1,080.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $788.00 | 2021 | |
| Medical Device Business Services, INC. | $751.70 | 2022 | |
| Boston Scientific Corporation | $271.37 | 2021-2024 | Watchman Flx |
| Cvrx, INC. | $165.44 | 2021 | |
| Sanofi-Aventis U.S. LLC | $123.14 | 2021 | |
| Irhythm Technologies, INC. | $40.86 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Seiler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.